Cited by 14Nanoparticle-Based Drug DeliveryCharacterization and Applications of Magnetic NanoparticlesNanoparticles: synthesis and applications

The DOI matches its Crossref record; 94 of the 94 references it cites were found in a registry or an index; none of the 152 sources its claims cite is checked for support yet.

Advances in green-synthesized magnetic nanoparticles for targeted cancer therapy: mechanisms, applications, and future perspectives

Open access
El-khawaga, Ahmed M., Youssef, Omneya Ibrahim, El-dydamoni, Omnia A., Ragab, Waleed Mahmoud, Mohammed, Rehab Abd Elfattah·2026·European Journal of Medical Research

Abstract

Magnetic nanoparticles (MNP) have gained significant attention for their potential in cancer therapy, particularly in targeted drug delivery, imaging, and hyperthermia treatments due to their unique magnetic properties, biological compatibility and applicability. This literature review focuses on recent progress in the green-synthesized MNP, explores their mechanisms of drug delivery, and critically evaluates their clinical applicability. The gaps in the literature that this review addresses include the inconsistency in nanoparticle size and surface properties, the limitations in achieving sustained and predictable drug release, and the difficulties in maintaining long-term stability in physiological conditions. It also discusses potential future development, including smart nanotechnology, individual medicine, and AI-acquired platforms. These findings show how MNPs can increase precise oncology by increasing medical effect, reducing toxicity and lightweight real-time monitoring of treatments.

Overview

AI snapshot

Written from the paper’s full text.

TL;DR

This narrative review surveys green-synthesized magnetic nanoparticles (MNPs) for cancer therapy, covering synthesis routes, magnetic and biocompatibility properties, passive/active/magnetic targeting mechanisms, and preclinical case studies. It argues MNPs offer multifunctional theranostic potential but that reproducibility, stability, controlled release, and scalability remain unresolved barriers to clinical translation.

Key findings

  • Green synthesis using plant phytochemicals (polyphenols, flavonoids, terpenoids, alkaloids, tannins) or microorganisms (e.g., *Bacillus subtilis*, *Aspergillus niger*) reduces Fe³⁺ salts to magnetite (Fe₃O₄) or maghemite (γ-Fe₂O₃) under mild conditions, with the biomolecules acting as both reducing and capping agents.
  • Superparamagnetism emerges below a critical diameter of typically 20–30 nm, eliminating residual magnetism that would otherwise drive aggregation; suitable EPR-based passive accumulation is cited at 10–200 nm.
  • Green-synthesized MNPs reportedly show "more than 90% of the cell's viability at high concentrations" in in vitro cytotoxicity assays, attributed to the absence of harmful chemicals.
  • Case studies: folate-targeted doxorubicin-loaded MNPs (25 nm, 10 mg/mL loading) gave a 60% tumor volume reduction versus controls with ~85% drug released over 48 h and no cardiotoxicity; PEG-coated, CA-125-antibody-conjugated paclitaxel MNPs (30 nm, 15 mg/mL) reduced tumor volume by 75% after two weeks, with 90% survival versus 50% in controls and release over 72 h.

Methods

  • Design: literature review (narrative) of green-synthesized MNPs for cancer therapy, organized around cancer therapy challenges, drug delivery systems, green synthesis, MNP characteristics, targeting mechanisms, case studies, comparative studies, challenges, and future perspectives.
  • Data: no primary data; evidence drawn from cited published studies, including the doxorubicin breast cancer and paclitaxel ovarian cancer preclinical examples, plus comparative tables of MNP versus traditional carriers.
  • Analysis: qualitative synthesis with descriptive tables (Table 1 targeting mechanisms; Table 2 comparative features) and adapted schematic figures; no systematic search strategy, inclusion criteria, or quantitative meta-analysis is described.

Limitations

  • Stated by the paper: batch-to-batch reproducibility is limited because size, shape, surface charge, and magnetic behavior are highly sensitive to temperature, pH, and precursor concentration; MNPs aggregate in physiological media via van der Waals and magnetic dipole interactions; long-term toxicity and clearance of degradation products (free iron ions) are only partially resolved; green synthesis is not yet optimized for industrial scale and may be costly; drug release rates vary with coating, particle size, drug hydrophobicity, and tumor microenvironment stimuli; and targeting performance is inconsistent across tumor types due to heterogeneity.
  • Evident from the text: the review states no systematic search or selection methodology, so coverage and conclusions may reflect selective citation; the two headline case studies are drawn from other groups' work and the paper itself notes that "further studies with larger sample sizes and varied tumor types are needed to validate the reproducibility and generalizability of these findings"; several claims are asserted without accompanying quantitative data (e.g., long-term excretion in animal models), and some reference attributions appear mismatched to the described studies.

Model-written summary. Check it against the paper before relying on it.

Integrity signals

Registry

Crossref · 10.1186/s40001-025-03804-9

Cites

94 of 94 references verified0 citation errors · 0 not checkable

Statistics

Nothing to recompute.

Verification

Claims the paper makes

0 of 152 cited sources checked · 0 supported · 0 flagged

Show all 87 claims

  • It may state two separate claims as one. 45
  • Probably not a substantial claim. 7
51 of 51
  • The paper relies on this without support.

    Magnetic targeting has obstacles related to insufficient tissue penetration and difficulty in accurately locating the desired site.

    “Magnetic targeting has obstacles related to insufficient tissue penetration and difficulty in accurately locating the desired site.”
  • The paper relies on this without support.

    Phytochemicals act as both reductants and stabilizers, converting metal salts such as iron chloride into magnetite (Fe3O4) or maghemite (γ-Fe2O3) NPs.

    “These compounds act as both reduced and stabilizers, which convert the metal salts such as iron chloride into magnetite (Fe3O4) or maghemite (γ-Fe2O3) NPs.”
  • The paper relies on this without support.

    Microorganisms have enzymatic systems and metabolic pathways that enable them to reduce metal ions and control particle size.

    “Microorganisms have enzymatic systems and metabolic passages that enable them to reduce metal ions and control the particle size and size.”
  • The paper relies on this without support.

    Surface modifications are necessary to prevent aggregation and increase stability of MNPs in the physical environment.

    “However, surface modifications are necessary to prevent aggregation and increase the stability of the physical environment as indicated in Fig. 4.”
  • The paper relies on this without support.

    Passive targeting is based on the EPR effect; tumor tissue contains blood vessels dripping and poor lymphatic drainage, allowing appropriate NPs (usually 10–200 nm) to accumulate at the tumor site.

    “Passive targeting is based on the enhanced permeability and retention (EPR) effect observed in tumor vasculature. Tumor tissue contains blood vessels dripping and poor lymphatic drainage, which allows appropriate NPs (usually 10–200 nm), preferably at the tumor site.”
  • The paper relies on this without support.

    Active targeting involves functionalization of MNP surfaces with specific ligands, antibodies, peptides, or aptamers that recognize and bind molecular markers overexpressed on cancer cells; this selective bond increases cellular uptake through receptor-mediated endocytosis and improves drug accumulation at the target site.

    “Active targeting involves functionalization of MNP surfaces with specific ligands, antibodies, peptides, or aptamers that recognize and bind molecular markers that are large over the cancer cells. General goals include folate receptors, HER2/NEU, and transferrin receptors. This selective bond increases cellular recording through the receptor-medieval endocytosis and improves drug accumulation at”
  • The paper relies on this without support.

    When biodegradable coatings and stimulation are connected with mechanism of post-release (e.g., pH-sensitive polymer), MNPs may release medications specifically within tumor microenvironment.

    “When biodegradable coatings and stimulation are connected with the mechanism of post-release (e.g., pH-sensitive polymer), MNPs may release medications specifically within tumor microenvironment.”
  • The paper relies on this without support.

    When cancer cells are inner, MNPs usually leave their medical cargo either through environmental trigger (e.g., acidic pH, enzyme) or through decline of nanoparticles; this localized release increases intracellular drug concentrations and can start apoptosis or prevent proliferative pathways.

    “When the cancer cells are inner, MNPs usually leave its medical cargo either through the environmental trigger (e.g., acidic pH, enzyme) or through the decline of nanoparticles. This localized release increases intracellular drug concentrations and can start apoptosis or prevent proliferative pathways.”
  • The paper relies on this without support.

    The most prominent route of MNP internalization is receptor-mediated endocytosis; functionalized nanoparticles interact and bind with specific receptors on cancer cell surface and are engulfed into endosomes; intracellular environment has variations in pH or enzyme activity to trigger drug release; higher drug concentration within cancer cell has greater cytotoxic effect while protecting body'ssur

    “The most prominent route of MNP’s internalization is with receptor-mediated endocytosis. Functionalized nanoparticles interact and bind with specific receptors on the cancer cell surface and will be engulfed into endosomes. The intracellular environment has variations in pH or enzyme activity to trigger drug release from the nanoparticle to elicit a local effect. The higher drug concentration”
  • The paper relies on this without support.

    Iron-oxide cores can produce reactive oxygen species (ROS) through Fenton-like reactions, causing oxidative stress and damage to DNA, proteins, and lipids; oxidative damage can induce mitochondrial dysfunction and loss of membrane potential, followed by activation of apoptotic pathways.

    “Iron-oxide cores can produce reactive oxygen species (ROS) through Fenton-like reactions, which can cause oxidative stress and damage components of the cell, such as DNA, proteins, and lipids. Oxidative damage can induce mitochondrial dysfunction and loss of membrane potential, followed by activation of apoptotic pathways.”
  • The paper relies on this without support.

    In the presence of an alternating magnetic field, MNPs can generate localized heat (magnetic hyperthermia), increasing tumor tissue temperature up to a level that causes protein denaturation and ultimately cell death; hyperthermia can provide a synergistic effect on chemotherapy or radiation, enhancing therapeutic effect.

    “In the presence of an alternating magnetic field, MNPs can generate localized heat (magnetic hyperthermia), which increases the tumor tissue temperature up to a level that causes protein denaturation and ultimately cell death. Hyperthermia can also provide a synergistic effect on chemotherapy or radiation, thereby enhancing the therapeutic effect.”
  • The paper relies on this without support.

    The gaps in the literature that this review addresses include inconsistency in nanoparticle size and surface properties, limitations in achieving sustained and predictable drug release, and difficulties in maintaining long-term stability in physiological conditions.

    “The gaps in the literature that this review addresses include the inconsistency in nanoparticle size and surface properties, the limitations in achieving sustained and predictable drug release, and the difficulties in maintaining long-term stability in physiological conditions.”
  • The paper relies on this without support.

    MNPs are biocompatible.

    “While MNPs are often considered biocompatible, their long-term accumulation and degradation products (e.g., free iron ions) may induce oxidative stress or interfere with normal cellular processes.”
  • The paper relies on this without support.

    Green synthesis methods are eco-friendly.

    “Green synthesis methods, though eco-friendly, are not yet optimized for industrial-scale production.”
14 of 14

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

Each contradiction between two passages listed here was confirmed by an independent check.

  • Targeted therapies are described as both lowering specificity and increasing selectivity

    Minor

    The overview says the proposed therapeutic approaches improve treatment by lowering drug specificity, while the targeted-delivery section says active targeting makes delivery more selective.

1 of 1

Cited works that were retracted

Works this paper cites that were later retracted, from the retraction notices publishers deposit. Major when the notice came out before this paper was published.

  • Cites a retracted work: 10.3390/cancers13143396

    Info

    The cited work was retracted on 2026-06-30 (notice 10.3390/cancers18132119), not before this paper was published (2026-02-07).

    Cited work 10.3390/cancers13143396 · retracted 2026-06-30 · notice 10.3390/cancers18132119 · this paper published 2026-02-07

1 of 1

Citations

Cites

1 retracted

Flagged first, then by citations

Show all 94 references

Research works printed but not linked: 11

  1. Bray F, et al. Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin. 2018;68(6):394–424.
  2. Ibrahim, N.A., et al. Heme oxygenase – 1 Expression in Liver and Colon of Rats Exposed to Oxidative stress and Dysplasia by a Carcinogen Diethylnitrosamine and the Possible Therapeutic Effects of Probiotic Versus Pyridazine Derivative and Chemotherapy. Egypt J Chem. 2022; 65(4): 249-268.
  3. Rarokar N, et al. Magnetic nanosystem a tool for targeted delivery and diagnostic application: current challenges and recent advancement. Int J Pharmaceutics: X. 2024;7:100231.
  4. Prieložná J, Mikušová V, Mikuš P. Advances in the delivery of anticancer drugs by nanoparticles and chitosan-based nanoparticles. Int J Pharmaceutics: X. 2024;8:100281.
  5. Yusoff AHM, Salimi MN, Jamlos MF. A review: synthetic strategy control of magnetite nanoparticles production. Adv Nano Res. 2018;6(1):1.
  6. Kirubakaran D, et al. A comprehensive review on the green synthesis of nanoparticles: advancements in biomedical and environmental applications. Biomed Mat Devices. 2026;4(1):388–413. · DOI · Paper page
  7. Chen Y, Su YC, Roffler SR. Polyethylene glycol immunogenicity in nanomedicine. Nat Rev Bioeng. 2025;10:1–9.
  8. Stiufiuc G, Stiufiuc R. Magnetic nanoparticles: synthesis, characterization, and their use in biomedical field. Appl Sci. 2024;14:1623. · DOI
  9. Koca E. New approaches in treatment of acute myeloid leukemia. Medicine. 2022;11:914.
  10. Ejeta BM, Das MK, Das S. Recent advances in Paclitaxel drug delivery: challenges, innovations, and future directions. Integr Biomed Res. 2024;8(8):1–13.
  11. Ghosh N, et al. Natural nanoparticles aid in the treatment of diabetes and cancer: a review.

Cited by

Sorted by citations

See all 14

Metadata

Authors
El-khawaga, A. M., Youssef, O. I., El-dydamoni, O. A., Ragab, W. M., & Mohammed, R. A. E.
Affiliations
  • Ibn Sina National College for Medical Studies (SA)
  • Al-Azhar University (EG)
  • Galala University (EG)
Venue
European Journal of Medical Research
Published
2026-02-07
Volume
31
Issue
1
ISSN
  • 0949-2321 (ISSN-L)
  • 2047-783X
OpenAlex
W7128299787
Cited by
14
References
94
Citations by year
2026: 14
FWCI
5.02
Type
journal article
Language
en
Open access
Locations
  • European journal of medical research (publishedVersion, cc-by)
  • PubMed (publishedVersion)
  • PubMed Central (publishedVersion, cc-by)
  • DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion)
Funders
Galala University
Topics
  • Physical Sciences › Materials Science › Biomaterials › Nanoparticle-Based Drug Delivery
  • Physical Sciences › Engineering › Biomedical Engineering › Characterization and Applications of Magnetic Nanoparticles
  • Physical Sciences › Materials Science › Materials Chemistry › Nanoparticles: synthesis and applications
Keywords
magnetic nanoparticles, green synthesis, targeted cancer therapy, targeted drug delivery, hyperthermia, magnetic resonance imaging, nanoparticle stability, controlled drug release, personalized medicine

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

A language model drew the claims from the paper on 2026-11-10, under version 3 of the claim definition (model deepseek-v4.1-flash, prompt extract-v3).

A second model labelled each claim on 2026-11-10 (model jev-1.13-20260917, definition revision gold-guideline-v0.2).

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review